Skip to content

Nano Nuclear Energy NNE Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

STU
StubHub Holdings, Inc.STUB
$2.06M
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
KDK
Kodiak AI, Inc. Common StockKDK
$0-100%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$126K-60.5%
Piedmont Office Realty Trust logo
Piedmont Office Realty TrustPDM
$106K-36.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$17K

Other financials

Income statement

See full
Net income-$9.2M+56.9%
EPS (diluted)-$0.18+68.4%

Balance sheet

See full
Cash & equivalents$197.7M+66.7%
Total debt$2.6M-8.7%
Total equity$595.9M+351%
Total assets$603.9M+335%

Cash flow

See full
Operating cash flow-$5.3M-121%
CapEx$4.6M+994%
Free cash flow-$9.6M-276%

Valuation

See full
Market cap$1.21B-22.0%
Enterprise value$1.01B-29.3%

Returns & leverage

See full
Return on equity-8.6%-3.9pp
Debt / equity0.0×
Current ratio95.7×+68.5×

Where this comes from

Reported directly by Nano Nuclear Energy in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Nano Nuclear Energy’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nano Nuclear Energy's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nano Nuclear Energy's payments of stock issuance costs?
Nano Nuclear Energy (NNE) reported payments of stock issuance costs of $21.52M in Q4 2025.
How has Nano Nuclear Energy's payments of stock issuance costs changed year-over-year?
Nano Nuclear Energy's payments of stock issuance costs increased by 137.6% year-over-year, from $9.06M to $21.52M.
What does payments of stock issuance costs mean?
Measures the direct costs incurred in the process of raising capital through the issuance of equity, such as underwriting fees, legal expenses, and registration costs. High issuance costs relative to proceeds can indicate inefficiencies in the capital-raising process. This metric is essential for understanding the net benefit of equity financing activities.